Atrial Fibrillation (AF) Patients Not Taking Vitamin-K Antagonist (VKA)

NCT00623779 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

128

Enrollment

INDUSTRY

Sponsor class

Conditions

Persistent or Permanent Non-valvular Atrial Fibrillation

Interventions

DRUG: AZD0837
DRUG: Aspirin

Sponsor

AstraZeneca